Decker, S.O.; Krüger, A.; Wilk, H.; Uhle, F.; Bruckner, T.; Hofer, S.; Weigand, M.A.; Brenner, T.; Zivkovic, A.R.
Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation. Biomolecules 2022, 12, 989.
https://doi.org/10.3390/biom12070989
AMA Style
Decker SO, Krüger A, Wilk H, Uhle F, Bruckner T, Hofer S, Weigand MA, Brenner T, Zivkovic AR.
Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation. Biomolecules. 2022; 12(7):989.
https://doi.org/10.3390/biom12070989
Chicago/Turabian Style
Decker, Sebastian O., Albert Krüger, Henryk Wilk, Florian Uhle, Thomas Bruckner, Stefan Hofer, Markus A. Weigand, Thorsten Brenner, and Aleksandar R. Zivkovic.
2022. "Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation" Biomolecules 12, no. 7: 989.
https://doi.org/10.3390/biom12070989
APA Style
Decker, S. O., Krüger, A., Wilk, H., Uhle, F., Bruckner, T., Hofer, S., Weigand, M. A., Brenner, T., & Zivkovic, A. R.
(2022). Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation. Biomolecules, 12(7), 989.
https://doi.org/10.3390/biom12070989
